Elizabeth Chapek, DO in Dallas, TX - Medicare Osteopathic Manipulative Medicine

Elizabeth Chapek, DO is a medicare enrolled "Specialist" physician in Dallas, Texas. She graduated from medical school in 1989 and has 35 years of diverse experience with area of expertise as Osteopathic Manipulative Medicine. Her current practice location is 6760 Abrams Rd, Suite 203, Dallas, Texas. You can reach out to her office (for appointments etc.) via phone at (214) 341-8742.

Elizabeth Chapek is licensed to practice in Texas (license number H7956) and she also participates in the medicare program. She may accept medicare assignments (which means she may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and her NPI Number is 1013076116.

Contact Information

	Elizabeth Chapek, DO
	6760 Abrams Rd, Suite 203, Dallas, TX 75231
	(214) 341-8742
	Not Available

Physician's Profile

Full Name	Elizabeth Chapek
Gender	Female
Speciality	Osteopathic Manipulative Medicine
Experience	35 Years
Location	6760 Abrams Rd, Dallas, Texas
Accepts Medicare Assignments	May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.

Medical Education and Training:

Elizabeth Chapek graduated from medical school in 1989

NPI Data:

NPI Number: 1013076116
Provider Enumeration Date: 12/06/2006
Last Update Date: 07/19/2018

Medicare PECOS Information:

PECOS PAC ID: 5890973598
Enrollment ID: I20110628000871

Medical Identifiers

Medical identifiers for Elizabeth Chapek such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013076116	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	H7956 (Texas)	Secondary
174400000X	Specialist	H7956 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth Chapek is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Elizabeth Chapek, DO 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Ph: (214) 341-8742	Elizabeth Chapek, DO 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Ph: (214) 341-8742

News Archive

Depomed submits Serada NDA with FDA for treatment of menopausal hot flashes

Depomed, Inc. today announced that it has submitted a New Drug Application (NDA) for Serada to the United States Food and Drug Administration. Serada is Depomed's proprietary extended release formulation of gabapentin in development for the treatment of menopausal hot flashes.

Genes account for approximately 30 percent of longevity in humans

Current research indicates that genes account for approximately 30 percent of longevity in humans which means that healthy habits play a large role in determining lifespan but good genes do help and the question now is how

Illumina to defend Genome Analyzer System patent infringement suit

Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.

Scientists decode the antihypertensive impact of omega-3 fatty acids

Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of Alzheimer's disease in older adults.

Elizabeth Chapek, DO - Medicare Osteopathic Manipulative Medicine in Dallas, TX